Citigroup Cuts agilon health (NYSE:AGL) Price Target to $1.75

agilon health (NYSE:AGL) had its price target lowered by Citigroup from $2.50 to $1.75 in a research note issued to investors on Wednesday morning,Benzinga reports. The firm currently has a sell rating on the stock.

AGL has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft decreased their price target on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Evercore ISI cut their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 8th. Barclays cut their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Stifel Nicolaus cut their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday. Finally, TD Cowen cut their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, agilon health has an average rating of “Hold” and a consensus price target of $6.38.

agilon health Price Performance

agilon health stock opened at $1.59 on Wednesday. The business’s 50-day simple moving average is $3.05 and its 200 day simple moving average is $4.86. The stock has a market cap of $653.05 million, a price-to-earnings ratio of -1.69 and a beta of 0.60. agilon health has a 12-month low of $1.58 and a 12-month high of $13.76. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the business earned ($0.06) EPS. As a group, research analysts anticipate that agilon health will post -0.43 earnings per share for the current year.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. The trade was a 42.03 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is currently owned by corporate insiders.

Institutional Trading of agilon health

Hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after purchasing an additional 371,537 shares during the last quarter. AQR Capital Management LLC raised its holdings in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its holdings in agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after acquiring an additional 316,856 shares in the last quarter. Capital International Investors raised its holdings in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Finally, Simplicity Wealth LLC raised its holdings in agilon health by 145.1% in the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after acquiring an additional 15,515 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.